Boston-based Biolojic Design announced Tuesday that the first-ever computationally-designed human antibody will enter the clinic. The company will study AU-007 in solid cancer tumors.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,